ADVFN - Advanced Financial Network.
HOME» LSE » G » GSK Share Price » GSK Share News

Glaxosmithkline Share News

 Glaxosmithkline Share Price
GSK Share Price
 Glaxosmithkline Share Chart
GSK Share Chart
 Glaxosmithkline Share News
GSK Share News
 Glaxosmithkline Company Information
GSK Company Information
 Glaxosmithkline Share Trades
GSK Share Trades
 Glaxosmithkline Share Message Board
GSK Share Message Board

GlaxoSmithKline to close Crawley factory in Sussex, 493 jobs to go

LONDON (Thomson Financial) - GlaxoSmithKline PLC. has announced hundreds of people will lose their jobs when it closes its factory in Sussex in 2011, the BBC reported citing a company spokesman. Some 493 people are expected to be affected when the multinational drugs company's Crawley site closes. The company blamed the closure on "declining volumes, regulatory delays and patent expiries". A spokesman said production at the site would continue until the products had been moved to alternative facilities. The spokesperson said: "GSK sincerely regrets the potential impact of this proposal in terms of job losses and will do all it can to help staff through this difficult period. "Implementation of this proposal will be subject to consultation with trade union and staff representatives at the Crawley site. This process will begin immediately." The factory currently produces medicines to treat Parkinson's disease, heart disease, HIV/AIDS, bacterial skin infections, depression, and hypertension. slm COPYRIGHT Copyright Thomson Financial News Limited 2008. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.

Share News for Glaxosmithkline (GSK)
24/04/201407:40:06Novartis 1st Quarter Profit Rises About 23%
24/04/201407:27:06Novartis First-Quarter Profit Rises About 23% -- Update
22/04/201418:06:07LONDON MARKETS: Glaxo, AstraZeneca Lead U.K. Stocks To Two-week...
22/04/201417:38:25EUROPE MARKETS: Drug Stocks Drive European Markets Higher
22/04/201414:50:05Glaxo Exits Cancer Drugs
22/04/201414:44:35LONDON MARKETS: Glaxo, AstraZeneca Lead Gains In U.K. Stocks
22/04/201413:32:05Novartis Overhauls Portfolio With Deals Worth $25 Billion...
22/04/201410:51:23Novartis Overhauls Portfolio With Deals Worth $25 Billion...
22/04/201409:40:14European Stocks Start Strongly After Easter Holiday
22/04/201408:16:43Novartis Overhauls Portfolio With Deals Worth $25 Billion...
17/04/201417:45:09GSK Says Incruse Gets Approval in Canada for Treatment of Lung...
16/04/201423:18:31ADR Shares End Higher; Credit Suisse, ASML Shares Active
16/04/201419:20:44Glaxo Investigating Bribery Claims in Jordan and Lebanon
15/04/201422:02:39ADR Shares End Lower; Infosys, Diageo Shares Active
15/04/201419:40:21Glaxo Wins U.S. Approval for Diabetes Drug
15/04/201419:29:21Glaxo Wins U.S. Approval for Diabetes Treatment Albiglutide
15/04/201418:33:19GlaxoSmithKline Gets FDA Approval for Diabetes Drug
14/04/201422:00:46ADR Shares End Mostly Higher; JA Solar Shares Active
14/04/201418:20:46LONDON MARKETS: FTSE 100 Turns Higher As Mining Stocks Strengthen
14/04/201418:00:03EUROPE MARKETS: European Stocks Swing To Gains Following Sell...

Glaxosmithkline Plc and other London Stock Exchange share prices are delayed by at least 20 minutes.
All other share price data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations